Gilead Sciences, Inc. , a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
Gilead Sciences stock last closed at $79.14, down 0.4% from the previous day, and has increased 32.65% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.29 percentage points. Gilead Sciences stock is currently +38.44% from its 52-week low of $57.17, and -11.81% from its 52-week high of $89.74.
There are currently 1.25B GILD shares outstanding. The market value of GILD is $98.70B. In the last 24 hours, 4.44M GILD shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy GILD stock.
Based on our research, eToro is the best brokerage. eToro gives you:
Get $10 towards your stock purchase by creating an account with eToro now.Open eToro Account
Now that you've picked the right brokerage, you need to fill out some personal details so you can invest in GILD today.
Now that you've filled out your info on one of the most highly reviewed stock market apps, you can securely and quickly fund your account:
Watch the tutorial below to see the process of transferring funds into your new investment account.
After you have decided on the best place to buy Gilead Sciences stock, it's crucial to research their stock prior to buying, so you truly wrap your head around the risk and opportunity.
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on GILD's stock page.
You can use many financial metrics, analyses, models, and charts to gauge GILD's intrinsic value.
Using relative valuations measures:
You can access additional valuation analysis on GILD's stock here.
Out of 14 Wall Street analysts who monitor GILD, the consensus analyst rating on Gilead Sciences is a Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Brian Abrahams, a top 3% analyst from RBC Capital maintains GILD with a hold rating and lowers their GILD price target from $87.00 to $86.00, on Mar 6, 2023.
Salim Syed, a bottom 14% analyst from Mizuho maintains GILD with a strong buy rating and raises their GILD price target from $88.00 to $101.00, on Feb 14, 2023.
David Risinger, a top 9% analyst from SVB Leerink maintains GILD with a hold rating and raises their GILD price target from $81.00 to $91.00, on Feb 3, 2023.
Matthew Harrison, a bottom 4% analyst from Morgan Stanley maintains GILD with a hold rating and raises their GILD price target from $80.00 to $81.00, on Feb 3, 2023.
Do Kim, a bottom 15% analyst from Piper Sandler maintains GILD with a strong buy rating and raises their GILD price target from $111.00 to $112.00, on Feb 3, 2023.
You can dive deeper into what analysts are saying on the Gilead Sciences stock forecast page.
Last year, GILD earnings were $4.59B. In the past 5 year, GILD's earnings have increased by 0.67% per year. This was slower than the Drug Manufacturers - General industry average of 25.66%.
Last year, GILD revenue was $27.28B. In the past 5 year, GILD's revenue has gone up by 0.88% per year. This was slower than the Drug Manufacturers - General industry average of 8.34%.
Dive into GILD's earnings and revenue performance here.
In the last year, insiders at GILD have sold more shares than they have bought.
Merdad Parsey, Chief Medical Officer of GILD, was the latest GILD insider to sell. They sold $483,892.74 worth of GILD stock on Mar 13, 2023.
Get more info about who owns GILD stock here.
Gilead Sciences pays a dividend of 3.71%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.18%. If you owned $1,000 worth of GILD stock, you would have been paid $37.15 last year.
Gilead Sciences dividend payments have consistently grown over the past 8 years and have remained stable.
Find more info about Gilead Sciences dividend yield and history here.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
There are two primary options:
Press the Open Trade button and your broker will execute your order.
If you want additional assistance buying stocks on eToro, click the helpful video below:
Now that you own some GILD stock, you'll want to stay up-to-date on your new stock purchase.
Put GILD on a watchlist to track your GILD stock.
To reiterate, here are the 6 steps to buy stock in Gilead Sciences:
If you require a brokerage account, eToro is our recommended option.Get Started with eToro Today
If you would like to get updates on your investment in Gilead Sciences, create your watchlist below.
How much does it cost to buy one Gilead Sciences share?
Is now a good time to buy Gilead Sciences stock?
What is the best way to buy Gilead Sciences stock?